Display options
Cite
Campbell PT, Krim SR, Lavie CJ, et al. Clinical characteristics, treatment patterns and outcomes of Hispanic hypertensive patients. Prog Cardiovasc Dis. 2014;57(3):244-52doi: 10.1016/j.pcad.2014.08.006.
Campbell, P. T., Krim, S. R., Lavie, C. J., & Ventura, H. O. (2014). Clinical characteristics, treatment patterns and outcomes of Hispanic hypertensive patients. Progress in cardiovascular diseases, 57(3), 244-52. https://doi.org/10.1016/j.pcad.2014.08.006
Campbell, Patrick T, et al. "Clinical characteristics, treatment patterns and outcomes of Hispanic hypertensive patients." Progress in cardiovascular diseases vol. 57,3 (2014): 244-52. doi: https://doi.org/10.1016/j.pcad.2014.08.006
Campbell PT, Krim SR, Lavie CJ, Ventura HO. Clinical characteristics, treatment patterns and outcomes of Hispanic hypertensive patients. Prog Cardiovasc Dis. 2014 Nov-Dec;57(3):244-52. doi: 10.1016/j.pcad.2014.08.006. Epub 2014 Aug 13. PMID: 25537632.
Copy Download .nbib Format: NLM
Share it on

Prog Cardiovasc Dis. 2014 Nov-Dec;57(3):244-52. doi: 10.1016/j.pcad.2014.08.006. Epub 2014 Aug 13.

Clinical characteristics, treatment patterns and outcomes of Hispanic hypertensive patients.

Progress in cardiovascular diseases

Patrick T Campbell, Selim R Krim, Carl J Lavie, Hector O Ventura

Affiliations

  1. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic School-the University of Queensland School of Medicine, New Orleans, LA, USA; Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70001, USA. Electronic address: [email protected].
  2. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic School-the University of Queensland School of Medicine, New Orleans, LA, USA; Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70001, USA. Electronic address: [email protected].
  3. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic School-the University of Queensland School of Medicine, New Orleans, LA, USA; Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70001, USA. Electronic address: [email protected].
  4. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic School-the University of Queensland School of Medicine, New Orleans, LA, USA; Department of Cardiology, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70001, USA. Electronic address: [email protected].

PMID: 25537632 DOI: 10.1016/j.pcad.2014.08.006

Abstract

Hispanics are the largest and fastest-growing minority population in the United States, currently comprising about 16.3% (52 million) of the total population. With an increased prevalence of metabolic risk factors in this population, the rate of uncontrolled hypertension (HTN) in Hispanics significantly exceeds the rates observed among non-Hispanic blacks and whites. Unfortunately, data on HTN in Hispanics remains limited due to the under-representation of Hispanics in clinical trials; with most of the data primarily restricted to observational and retrospective subgroup analyses. This article aims to review the available data on prevalence, awareness and control of HTN, risk factors and some of the challenges unique to the Hispanics population. We also discuss treatment strategies derived from large HTN trials that included Hispanics.

Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords: ACE; ALLHAT; ARB; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack; BP; CAD; CV; CVD; DBP; DM; Diabetes Mellitus; Epidemiology; HCTZ; HTN; Hispanics; JNC; Joint National Council; Latinos; MI; MetS; Mexican-Americans; SBP; SR; T2DM; Treatment; US; United States; angiotensin receptor blocker; angiotensin-converting enzyme; blood pressure; cardiovascular; cardiovascular disease; coronary artery disease; diastolic blood pressure; highly sensitive C-reactive protein; hsCRP; hydrochlorothiazide; hypertension; metabolic syndrome; myocardial infarction; sustained release; systolic blood pressure; type 2 diabetes mellitus

MeSH terms

Publication Types